JOINT CORP/THE (JYNT) Stock Fundamental Analysis
USA - NASDAQ:JYNT - US47973J1025 - Common Stock
7.89 USD
0 (0%)
7.89 USD
0 (0%)
Overall JYNT gets a fundamental rating of 3 out of 10. We evaluated JYNT against 101 industry peers in the Health Care Providers & Services industry. The financial health of JYNT is average, but there are quite some concerns on its profitability. JYNT is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year JYNT has reported negative net income.
JYNT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: JYNT reported negative net income in multiple years.
JYNT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
JYNT has a Return On Assets of -6.82%. This is in the lower half of the industry: JYNT underperforms 71.29% of its industry peers.
JYNT has a Return On Equity of -21.48%. This is in the lower half of the industry: JYNT underperforms 65.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.82% | ||
| ROE | -21.48% | ||
| ROIC | N/A |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
JYNT has a better Gross Margin (81.48%) than 95.05% of its industry peers.
In the last couple of years the Gross Margin of JYNT has declined.
The Profit Margin and Operating Margin are not available for JYNT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 81.48% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
2. Health
2.1 Basic Checks
JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
JYNT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for JYNT has been increased compared to 5 years ago.
JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 2.76 indicates that JYNT is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of JYNT (2.76) is comparable to the rest of the industry.
JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 2.76 |
ROIC/WACCN/A
WACC9.25%
2.3 Liquidity
A Current Ratio of 1.80 indicates that JYNT should not have too much problems paying its short term obligations.
JYNT has a Current ratio of 1.80. This is in the better half of the industry: JYNT outperforms 67.33% of its industry peers.
JYNT has a Quick Ratio of 1.80. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.80, JYNT is doing good in the industry, outperforming 68.32% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
JYNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.41%, which is quite impressive.
JYNT shows a decrease in Revenue. In the last year, the revenue decreased by -9.68%.
The Revenue has been growing slightly by 1.36% on average over the past years.
EPS 1Y (TTM)72.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.85%
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-56.15%
3.2 Future
The Earnings Per Share is expected to grow by 72.72% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -20.57% on average over the next years. This is quite bad
EPS Next Y98.84%
EPS Next 2Y91.55%
EPS Next 3Y72.72%
EPS Next 5YN/A
Revenue Next Year-54.02%
Revenue Next 2Y-28.81%
Revenue Next 3Y-20.57%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for JYNT. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 21.49, the valuation of JYNT can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of JYNT is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.52. JYNT is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 21.49 |
4.2 Price Multiples
JYNT's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.8 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
JYNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JYNT's earnings are expected to grow with 72.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y91.55%
EPS Next 3Y72.72%
5. Dividend
5.1 Amount
JYNT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.89
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners77.63%
Inst Owner Change-0.18%
Ins Owners8.65%
Ins Owner Change3.9%
Market Cap121.03M
Revenue(TTM)108.44M
Net Income(TTM)-4990300
Analysts78.18
Price Target15.17 (92.27%)
Short Float %3.74%
Short Ratio5.35
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.93%
Min Revenue beat(2)-2.34%
Max Revenue beat(2)-1.53%
Revenue beat(4)1
Avg Revenue beat(4)-12.67%
Min Revenue beat(4)-51.14%
Max Revenue beat(4)4.33%
Revenue beat(8)3
Avg Revenue beat(8)-6.08%
Revenue beat(12)4
Avg Revenue beat(12)-4.64%
Revenue beat(16)6
Avg Revenue beat(16)-3.78%
PT rev (1m)0%
PT rev (3m)-3.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-100%
EPS NY rev (1m)0%
EPS NY rev (3m)-107.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 21.49 | ||
| P/S | 1.12 | ||
| P/FCF | 35.8 | ||
| P/OCF | 25.52 | ||
| P/B | 5.21 | ||
| P/tB | 5.21 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.24
EYN/A
EPS(NY)0.37
Fwd EY4.65%
FCF(TTM)0.22
FCFY2.79%
OCF(TTM)0.31
OCFY3.92%
SpS7.07
BVpS1.51
TBVpS1.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.82% | ||
| ROE | -21.48% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 81.48% | ||
| FCFM | 3.12% |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
F-Score6
Asset Turnover1.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 52.4% | ||
| Cap/Sales | 1.26% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 2.76 |
F-Score6
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)57.36%
Cap/Depr(5y)93.23%
Cap/Sales(3y)6.25%
Cap/Sales(5y)6.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.85%
EPS Next Y98.84%
EPS Next 2Y91.55%
EPS Next 3Y72.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-56.15%
Revenue Next Year-54.02%
Revenue Next 2Y-28.81%
Revenue Next 3Y-20.57%
Revenue Next 5YN/A
EBIT growth 1Y-162.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year313.77%
EBIT Next 3Y73.96%
EBIT Next 5YN/A
FCF growth 1Y-70.37%
FCF growth 3Y6.31%
FCF growth 5Y15.29%
OCF growth 1Y-71.9%
OCF growth 3Y-12.05%
OCF growth 5Y4.6%
JOINT CORP/THE / JYNT FAQ
What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?
ChartMill assigns a fundamental rating of 3 / 10 to JYNT.
What is the valuation status for JYNT stock?
ChartMill assigns a valuation rating of 3 / 10 to JOINT CORP/THE (JYNT). This can be considered as Overvalued.
How profitable is JOINT CORP/THE (JYNT) stock?
JOINT CORP/THE (JYNT) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for JYNT stock?
The Earnings per Share (EPS) of JOINT CORP/THE (JYNT) is expected to grow by 98.84% in the next year.